SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-017702
Filing Date
2021-04-06
Accepted
2021-04-06 08:30:30
Documents
5
Period of Report
2021-05-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A phat-def14a_20201231.htm DEF 14A 853961
2 GRAPHIC gysqdavivwbg000001.jpg GRAPHIC 74526
3 GRAPHIC gysqdavivwbg000002.jpg GRAPHIC 74526
4 GRAPHIC gysqdavivwbg000003.jpg GRAPHIC 246949
5 GRAPHIC gysqdavivwbg000004.jpg GRAPHIC 217238
  Complete submission text file 0001564590-21-017702.txt   1699233
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39094 | Film No.: 21808181
SIC: 2834 Pharmaceutical Preparations